ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Invesco S&P SmallCap Financials ETF Trust II

Invesco S&P SmallCap Financials ETF Trust II (PSCF)

52.24
-0.3248
( -0.62% )
Actualizado: 11:23:42

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
52.24
Postura de Compra
52.38
Postura de Venta
52.46
Volume Operado de la Acción
927
51.90 Rango del Día 52.28
44.43 Rango de 52 semanas 62.2432
Capitalización de Mercado [m]
Precio Anterior
52.5648
Precio de Apertura
52.03
Última hora de negociación
11:17:17
Volumen financiero
US$ 48,295
Precio Promedio Ponderado
52.0986
Volumen promedio (3 m)
3,059
Acciones en circulación
370,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
4.14
Beneficio por acción (BPA)
12.63
turnover
643k
Beneficio neto
4.67M

Acerca de Invesco S&P SmallCap Financials ETF Trust II

The investment seeks to track the investment results (before fees and expenses) of the S&P SmallCap 600 Capped Financials & Real Estate Index. The fund generally will invest at least 90% of its total assets in the securities, which may include real estate investment trusts (REITs), of small-capitali... The investment seeks to track the investment results (before fees and expenses) of the S&P SmallCap 600 Capped Financials & Real Estate Index. The fund generally will invest at least 90% of its total assets in the securities, which may include real estate investment trusts (REITs), of small-capitalization U.S. financial service companies that comprise the underlying index. These companies are principally engaged in the business of providing financial services and products, including banking, investment services, insurance and real estate finance services. Mostrar más

Sector
Mgmt Invt Offices, Open-end
Industria
Mgmt Invt Offices, Open-end
Sitio web
Sede
Boston, Massachusetts, USA
Fundado
-
Invesco S&P SmallCap Financials ETF Trust II is listed in the Mgmt Invt Offices, Open-end sector of the NASDAQ with ticker PSCF. The last closing price for Invesco S&P SmallCap Fin... was US$52.56. Over the last year, Invesco S&P SmallCap Fin... shares have traded in a share price range of US$ 44.43 to US$ 62.2432.

Invesco S&P SmallCap Fin... currently has 370,000 shares in issue. The market capitalisation of Invesco S&P SmallCap Fin... is US$19.45 million. Invesco S&P SmallCap Fin... has a price to earnings ratio (PE ratio) of 4.14.

PSCF Últimas noticias

Invesco Provides Estimated Capital Gain Distribution Information for 2019

Invesco Provides Estimated Capital Gain Distribution Information for 2019 PR Newswire ATLANTA, Dec. 2, 2019 ATLANTA, Dec. 2, 2019 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ) a leading global...

Invesco Provides Estimated Capital Gain Distribution Information for 2018

Invesco Provides Estimated Capital Gain Distribution Information for 2018 PR Newswire ATLANTA, Nov. 30, 2018 ATLANTA, Nov. 30, 2018 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ) a leading global...

Invesco PowerShares Provides Estimated Capital Gains Information for 2015

Invesco PowerShares Provides Estimated Capital Gains Information for 2015 PR Newswire DOWNERS GROVE, Ill., Nov. 24, 2015 DOWNERS GROVE, Ill., Nov. 24, 2015 /PRNewswire/ -- Invesco PowerShares...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-3.21-5.7889990982955.4555.7951.9147054.11396985SP
4-7.23-12.157390280859.4759.6151.9182355.41882485SP
12-5.02-8.7670275934357.2662.243251.9305957.84138956SP
261.382.7133307117650.8662.243249.56301455.74425091SP
525.2511.172589912746.9962.243244.43211353.26815278SP
156-10.68-16.973935155862.9263.473638.28244050.23291007SP
260-3.23-5.8229673697555.4764.0929.46401150.1809833SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PHIOPhio Pharmaceuticals Corporation
US$ 6.47
(282.84%)
217.33M
SLRXSalarius Pharmaceuticals Inc
US$ 3.8855
(148.27%)
103.96M
ATPCAgape ATP Corporation
US$ 2.39
(89.68%)
74.61M
XXII22nd Century Group Inc
US$ 9.2178
(88.50%)
15.36M
VRMEVerifyMe Inc
US$ 4.3686
(71.32%)
33.53M
EHGOEshallgo Inc
US$ 1.10
(-66.36%)
2.53M
CMTLComtech Telecommunications Corporation
US$ 2.0601
(-50.12%)
2.98M
NAYANAYA Biosciences Inc
US$ 0.4912
(-39.61%)
729.9k
SVMHSRIVARU Holding Ltd
US$ 0.03755
(-39.24%)
129.11M
TCTMTCTM Kids IT Education Inc
US$ 0.457
(-37.79%)
751.73k
GCTKGlucoTrack Inc
US$ 0.1377
(17.69%)
603.16M
PHIOPhio Pharmaceuticals Corporation
US$ 6.47
(282.84%)
217.33M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0646
(-26.67%)
143.24M
SVMHSRIVARU Holding Ltd
US$ 0.03755
(-39.24%)
129.11M
NVDANVIDIA Corporation
US$ 132.56
(-2.46%)
124.55M
wadirum1 wadirum1 3 minutos hace
The audit has apparently taken about 10 years longer than expected, no?

Is there some point at which we should all just confront Eric on his BS? Or do you think it is for the best to just continue as if the decade of missed deadlines was all just some random sequence of events that
HHSE
Hosai Hosai 3 minutos hace
Even if you read it as needing another trial which is obv up for debate (also would be for FDA - EMA clearly not), it would still mean Anavex have better and more robust long term trial data (3-4 years) compared to any AD phase 2 previously done by a company.
Eli Lily jumped $15.3 billion (
AVXL
BarrellofHay BarrellofHay 3 minutos hace
Company alluded to a Phase 4.

"A phase 4 clinical trial, also known as a post-marketing surveillance trial, is a study that examines a drug's safety and effectiveness after it has been approved and is available for patients."

Key is that this is a study used afte
AVXL
gp22 gp22 3 minutos hace
$MITQ @ 70s: ..Volume elevating....Last of the AI microfloats yet to rip.
MITQ
BottomBounce BottomBounce 3 minutos hace
$NIO Book Value Per Share (mrq) $12.43 Total Cash (mrq) $36.27B
NIO
I-Glow I-Glow 3 minutos hace
That is why you are underwater on Spooz because you believe anything Spooz posts on X as true and factual. LOLOL!

Spooz
@SpoozInc
2h
$SPZI The increase in the Authorized Shares is to secure potential acquisitions and to support the culmination of the commodity and
SPZI
gp22 gp22 3 minutos hace
$MITQ @ 70s: ..Volume elevating....Last of the AI microfloats yet to rip.
MITQ
Hi_Lo Hi_Lo 4 minutos hace
You haven't stopped anything and you never will
I'm not trying to stop anything. Unlike you and your lying pumps that helps and furthers this scam, I'm simply warning people here with documentation that this is a scam and that Jake P. Noch has a history of perpetrating huge frauds - including
BCAP
Strukture Strukture 4 minutos hace
VRME for the win today!
VRME
doc2016 doc2016 4 minutos hace
emPath ....thinking nvidia now hiring asic engineers in taiwan. i wonder why china wants more influence in taiwan? asics and fpga; asics and memristors, which remembering em state can go to tha switching /gate position..with soft fabric and software stacks and api's with the emPath information....
IONQ
martyDg martyDg 4 minutos hace
If I were a betting person, I would bet that mRESVIA and DCVax-L will be among the drugs that are approved by MHRA in January.


Who's going tell him he's about to be wrong? Maybe, try February, March, April and so on. 😝
NWBO
Zorax Zorax 4 minutos hace
Trying wash trading to look like interest again? Lots of beneficial ownership shenanigans as usual. Tax write offs anyone?
UEEC
scortech scortech 4 minutos hace
I doubt same "Person". Buys are making MM's buy their shorts back
Did good slap an ask they'll lose their shorts and show their A$$
JMO.
CGAC
Investor2014 Investor2014 4 minutos hace
The ability of Anavex snatching defeat from the claws of victory is uncanny!
AVXL
BCCHoosier BCCHoosier 4 minutos hace
Spot on. We have used a few bullets already and going nowhere. If we do get bought out it will be for far less than any of us expected.
AVXL
jpike jpike 5 minutos hace
I now have the largest position in Pays that I have held in years. Looking forward to large gains in the next year or two on this one.
PAYS
peanutz peanutz 5 minutos hace
If you are depending on that it's ashame . You are in the wrong business.
IGPK
hedge_fun hedge_fun 5 minutos hace
Jeff if you recall, there was a promo…….

group that talked about the OS reduction through a Preferred offering about 2 years ago. It was when the pps ran up to around half a penny.

Then they dumped and stopped pumping.

But they mentioned it in a podcast
APRU
arachnodude arachnodude 5 minutos hace
You asked...

How many trolls like Slinger spend their days obsessively spreading cherry-picked, manipulated nonsense, ignoring facts, and attacking progress just to get a rise out of others? Unfortunately, the answer to that is: far too many.

🤣🤣🤣
KBLB
Zenos Arrow Zenos Arrow 5 minutos hace
I’m sure he’s still there Loc. Why would he leave – he’s still getting paid? The bigger question is, has he done enough to satisfy his six-month incentive metrics. If so, we should get an 8-K announcing that 500K more shares were granted via meeting these metrics. So, no communication forthcoming co
HDVY
Gator44 Gator44 5 minutos hace
https://ih.advfn.com/stock-market/NASDAQ/sana-biotechnology-SANA/stock-news/95237254/form-8-k-current-report
SANA
Mojocash Mojocash 5 minutos hace
Averaged down for a rainy day!
HLLK
linkvest linkvest 6 minutos hace
Eat those freakin awesome 5s up newbies. They are so cheap for a quality company that has so much on the horizon and about to explode any time now.
ASII
zab zab 6 minutos hace
https://www.yahoo.com/news/maga-republican-slammed-saying-california-003138819.html

Once again, Republicans from California, let's not pay for anything.

Su Consulta Reciente

Delayed Upgrade Clock